Title: Breast cancer resistance protein (BCRP/ABCG2) localises to the nucleus in glioblastoma multiforme cells.
Journal: Xenobiotica; the fate of foreign compounds in biological systems 20120801
Title: Asperjinone, a nor-neolignan, and terrein, a suppressor of ABCG2-expressing breast cancer cells, from thermophilic Aspergillus terreus.
Journal: Journal of natural products 20120427
Title: Metabolites from Aspergillus fumigatus, an endophytic fungus associated with Melia azedarach, and their antifungal, antifeedant, and toxic activities.
Journal: Journal of agricultural and food chemistry 20120404
Title: Serum-dependent export of protoporphyrin IX by ATP-binding cassette transporter G2 in T24 cells.
Journal: Molecular and cellular biochemistry 20111201
Title: Specific inhibition of the ABCG2 transporter could improve the efficacy of photodynamic therapy.
Journal: Journal of photochemistry and photobiology. B, Biology 20111103
Title: Inhibition of c-Kit, VEGFR-2 (KDR), and ABCG2 by analogues of OSI-930.
Journal: Bioorganic & medicinal chemistry letters 20111101
Title: Fungal indole alkaloid biosynthesis: genetic and biochemical investigation of the tryptoquialanine pathway in Penicillium aethiopicum.
Journal: Journal of the American Chemical Society 20110302
Title: Differential inhibition of murine Bcrp1/Abcg2 and human BCRP/ABCG2 by the mycotoxin fumitremorgin C.
Journal: European journal of pharmacology 20101010
Title: Specific inhibitors of the breast cancer resistance protein (BCRP).
Journal: ChemMedChem 20100903
Title: BCRP/ABCG2 confers anticancer drug resistance without covalent dimerization.
Journal: Cancer science 20100801
Title: Doxorubicin fails to eradicate cancer stem cells derived from anaplastic thyroid carcinoma cells: characterization of resistant cells.
Journal: International journal of oncology 20100801
Title: Novel structure-activity relationships and selectivity profiling of cage dimeric 1,4-dihydropyridines as multidrug resistance (MDR) modulators.
Journal: Bioorganic & medicinal chemistry 20100715
Title: Breast cancer resistance protein (BCRP)-mediated glyburide transport: effect of the C421A/Q141K BCRP single-nucleotide polymorphism.
Journal: Drug metabolism and disposition: the biological fate of chemicals 20100501
Title: Multiple efflux pumps are involved in the transepithelial transport of colchicine: combined effect of p-glycoprotein and multidrug resistance-associated protein 2 leads to decreased intestinal absorption throughout the entire small intestine.
Journal: Drug metabolism and disposition: the biological fate of chemicals 20091001
Title: Interaction of nilotinib, dasatinib and bosutinib with ABCB1 and ABCG2: implications for altered anti-cancer effects and pharmacological properties.
Journal: British journal of pharmacology 20091001
Title: Small intestinal efflux mediated by MRP2 and BCRP shifts sulfasalazine intestinal permeability from high to low, enabling its colonic targeting.
Journal: American journal of physiology. Gastrointestinal and liver physiology 20090801
Title: Bioactive alkaloids from endophytic Aspergillus fumigatus.
Journal: Journal of natural products 20090401
Title: Identification of cytochrome P450s required for fumitremorgin biosynthesis in Aspergillus fumigatus.
Journal: Chembiochem : a European journal of chemical biology 20090323
Title: Potent and selective inhibitors of breast cancer resistance protein (ABCG2) derived from the p-glycoprotein (ABCB1) modulator tariquidar.
Journal: Journal of medicinal chemistry 20090226
Title: ABCG2 is expressed in late spermatogenesis and is associated with the acrosome.
Journal: Biochemical and biophysical research communications 20090109
Title: Molecular expression and functional evidence of a drug efflux pump (BCRP) in human corneal epithelial cells.
Journal: Current eye research 20090101
Title: Application and limitation of inhibitors in drug-transporter interactions studies.
Journal: International journal of pharmaceutics 20080522
Title: Constitutive overexpression of P-glycoprotein, rather than breast cancer resistance protein or organic cation transporter 1, contributes to acquisition of imatinib-resistance in K562 cells.
Journal: Pharmaceutical research 20080401
Title: The breast cancer resistance protein (Bcrp1/Abcg2) limits fetal distribution of glyburide in the pregnant mouse: an Obstetric-Fetal Pharmacology Research Unit Network and University of Washington Specialized Center of Research Study.
Journal: Molecular pharmacology 20080301
Title: Functionalized chalcones as selective inhibitors of P-glycoprotein and breast cancer resistance protein.
Journal: Bioorganic & medicinal chemistry 20080101
Title: Porphyrin homeostasis maintained by ABCG2 regulates self-renewal of embryonic stem cells.
Journal: PloS one 20080101
Title: Expression of the ATP-binding cassette membrane transporter, ABCG2, in human and rodent brain microvessel endothelial and glial cell culture systems.
Journal: Pharmaceutical research 20070701
Title: C421 allele-specific ABCG2 gene amplification confers resistance to the antitumor triazoloacridone C-1305 in human lung cancer cells.
Journal: Biochemical pharmacology 20070630
Title: Energy transfer to analyse membrane-integrated mitoxantrone in BCRP-overexpressed cells.
Journal: Journal of photochemistry and photobiology. B, Biology 20070525
Title: Progesterone inhibits folic acid transport in human trophoblasts.
Journal: The Journal of membrane biology 20070401
Title: Zebrafish kidney marrow contains ABCG2-dependent side population cells exhibiting hematopoietic stem cell properties.
Journal: Differentiation; research in biological diversity 20070301
Title: Absorption of folate by Caco-2 cells is not affected by high glucose concentration.
Journal: European journal of pharmacology 20061203
Title: Complex interaction of BCRP/ABCG2 and imatinib in BCR-ABL-expressing cells: BCRP-mediated resistance to imatinib is attenuated by imatinib-induced reduction of BCRP expression.
Journal: Blood 20060715
Title: Expression and functional activity of breast cancer resistance protein (BCRP, ABCG2) transporter in the human choriocarcinoma cell line BeWo.
Journal: Clinical and experimental pharmacology & physiology 20060101
Title: Piperazinobenzopyranones and phenalkylaminobenzopyranones: potent inhibitors of breast cancer resistance protein (ABCG2).
Journal: Journal of medicinal chemistry 20051117
Title: Breast cancer resistance protein-mediated efflux of androgen in putative benign and malignant prostate stem cells.
Journal: Cancer research 20050801
Title: ABCG2-mediated transport of photosensitizers: potential impact on photodynamic therapy.
Journal: Cancer biology & therapy 20050201
Title: An improved definition of mouse mammary epithelial side population cells.
Journal: Cytotherapy 20050101
Title: Polyphasic taxonomy of Aspergillus fumigatus and related species.
Journal: Mycologia 20050101
Title: Aspergillus fumigatus CY018, an endophytic fungus in Cynodon dactylon as a versatile producer of new and bioactive metabolites.
Journal: Journal of biotechnology 20041109
Title: Liquid chromatography method for the quantitation of the breast cancer resistance protein ABCG2 inhibitor fumitremorgin C and its chemical analogues in mouse plasma and tissues.
Journal: Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20040805
Title: Fumagiringillin, a new fumagillin derivative from a strain of the fungus Aspergillus fumigatus.
Journal: Journal of natural products 20040801
Title: Broad-spectrum modulation of ATP-binding cassette transport proteins by the taxane derivatives ortataxel (IDN-5109, BAY 59-8862) and tRA96023.
Journal: Cancer chemotherapy and pharmacology 20040501
Title: Flavonoids are inhibitors of breast cancer resistance protein (ABCG2)-mediated transport.
Journal: Molecular pharmacology 20040501
Title: Single amino acid substitutions in the transmembrane domains of breast cancer resistance protein (BCRP) alter cross resistance patterns in transfectants.
Journal: International journal of cancer 20031210
Title: The role of breast cancer resistance protein in acute lymphoblastic leukemia.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research 20031101
Title: Breast cancer resistance protein exports sulfated estrogens but not free estrogens.
Journal: Molecular pharmacology 20030901
Title: Wild-type breast cancer resistance protein (BCRP/ABCG2) is a methotrexate polyglutamate transporter.
Journal: Cancer research 20030901
Title: Transport of methotrexate, methotrexate polyglutamates, and 17beta-estradiol 17-(beta-D-glucuronide) by ABCG2: effects of acquired mutations at R482 on methotrexate transport.
Journal: Cancer research 20030715
Title: Breast cancer resistance protein (BCRP/ABCG2) induces cellular resistance to HIV-1 nucleoside reverse transcriptase inhibitors.
Journal: Molecular pharmacology 20030101
Title: Isolation and toxigenicity of Aspergillus fumigatus from moldy silage.
Journal: Mycopathologia 20030101
Title: Penicillium digitatum metabolites on synthetic media and citrus fruits.
Journal: Journal of agricultural and food chemistry 20021023
Title: Potent and specific inhibition of the breast cancer resistance protein multidrug transporter in vitro and in mouse intestine by a novel analogue of fumitremorgin C.
Journal: Molecular cancer therapeutics 20020401
Title: Functional characterization of the human multidrug transporter, ABCG2, expressed in insect cells.
Journal: Biochemical and biophysical research communications 20010706
Title: Inhibition of BCRP-mediated drug efflux by fumitremorgin-type indolyl diketopiperazines.
Journal: Bioorganic & medicinal chemistry letters 20010108
Title: Overexpression of the ATP-binding cassette half-transporter, ABCG2 (Mxr/BCrp/ABCP1), in flavopiridol-resistant human breast cancer cells.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research 20010101
Title: Rabindran SK, et al. Reversal of a novel multidrug resistance mechanism in human colon carcinoma cells by fumitremorgin C. Cancer Res. 1998 Dec 15;58(24):5850-8.
Title: Rabindran SK, et al. Fumitremorgin C reverses multidrug resistance in cells transfected with the breast cancer resistance protein. Cancer Res. 2000 Jan 1;60(1):47-50.